Pediatric rheumatology

Sustained hippocampal neuroinflammation and subsequent glutamatergic dysfunction in juvenile idiopathic arthritis: evidence from proton magnetic resonance spectroscopy (1H-MRS)

Arthritis Res TherPublished Cross-sectional study

Authors' conclusion

Sustained hippocampal neuroinflammation (indicated by elevated mI/tCr) and the subsequent glutamatergic synaptic dysfunction (indicated by reduced Glu/tCr and Glx/tCr) were identified in JIA patients.

Study context

Population
Juvenile idiopathic arthritis (JIA) patients across active and inactive disease phases and healthy controls248 JIA patients
Participants
61 / 187 / 57
Exposure
Active JIA and inactive JIA vs healthy controls
  • Active JIAn = 61
  • Inactive JIAn = 187
  • Healthy controls (HCs)n = 57reference
Outcome
Right hippocampal metabolite ratios (tNAA, tCho, mI, Glu, Glx relative to tCr)
Methodological details1H-MRS of the right hippocampus
  • 1H-MRS of the right hippocampus

Main finding

As reported in the abstract

Hippocampal metabolite ratios vs HCs
  • Both JIA groups showed elevated myo-inositol (mI)/total creatine (tCr) vs HCs (all P < 0.05)
  • Reduced glutamate (Glu)/tCr and Glx/tCr in the inactive JIA group vs HCs (all P < 0.05)

Observational data: associations, not effects.

Further findings

Correlation of mI/tCr with systemic inflammation in active JIA

mI/tCr vs ESR, rho
0.269
mI/tCr vs CRP, rho
0.287
  • Did not survive the rigid multiple correction

tNAA/tCr, total choline (tCho)/tCr, Glu/tCr and Glx/tCr vs systemic inflammation and clinical indices

No significant correlations in treatment-naïve and inactive JIA

Original publication

Sustained hippocampal neuroinflammation and subsequent glutamatergic dysfunction in juvenile idiopathic arthritis: evidence from proton magnetic resonance spectroscopy (1H-MRS). Arthritis Res Ther. Published 30 December 2025. doi:10.1186/s13075-025-03695-5

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.